Sutro Biopharma Inc
NASDAQ:STRO

Watchlist Manager
Sutro Biopharma Inc Logo
Sutro Biopharma Inc
NASDAQ:STRO
Watchlist
Price: 3.579459 USD -9.61% Market Closed
Market Cap: 293.4m USD
Have any thoughts about
Sutro Biopharma Inc?
Write Note

Sutro Biopharma Inc
Cash from Financing Activities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Sutro Biopharma Inc
Cash from Financing Activities Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Cash from Financing Activities Analysis
Latest Figures & CAGR of Competitors

Company Cash from Financing Activities CAGR 3Y CAGR 5Y CAGR 10Y
Sutro Biopharma Inc
NASDAQ:STRO
Cash from Financing Activities
$84.2m
CAGR 3-Years
-20%
CAGR 5-Years
-9%
CAGR 10-Years
N/A
Abbvie Inc
NYSE:ABBV
Cash from Financing Activities
-$2.8B
CAGR 3-Years
45%
CAGR 5-Years
25%
CAGR 10-Years
1%
Gilead Sciences Inc
NASDAQ:GILD
Cash from Financing Activities
-$6.8B
CAGR 3-Years
0%
CAGR 5-Years
4%
CAGR 10-Years
-3%
Amgen Inc
NASDAQ:AMGN
Cash from Financing Activities
-$5.3B
CAGR 3-Years
0%
CAGR 5-Years
21%
CAGR 10-Years
N/A
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Cash from Financing Activities
-$1B
CAGR 3-Years
8%
CAGR 5-Years
-49%
CAGR 10-Years
N/A
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Cash from Financing Activities
-$1.5B
CAGR 3-Years
-55%
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Sutro Biopharma Inc's Cash from Financing Activities?
Cash from Financing Activities
84.2m USD

Based on the financial report for Jun 30, 2024, Sutro Biopharma Inc's Cash from Financing Activities amounts to 84.2m USD.

What is Sutro Biopharma Inc's Cash from Financing Activities growth rate?
Cash from Financing Activities CAGR 5Y
-9%

Over the last year, the Cash from Financing Activities growth was -55%. The average annual Cash from Financing Activities growth rates for Sutro Biopharma Inc have been -20% over the past three years , -9% over the past five years .

Back to Top